Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
Stephen L. Chan, Baek‐Yeol Ryoo, Frankie Mo, Landon L. Chan, Jaekyung Cheon, Leung Li, Kwan Hung Wong, Nicole Yim, Hyeyeong Kim, Changhoon Yoo
Topics & Concepts
CabozantinibHepatocellular carcinomaMedicineOncologyImmune checkpointInternal medicineImmunotherapyCancerRenal cell carcinomaHepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersCholangiocarcinoma and Gallbladder Cancer Studies